Novel Insights into the Role of the Mineralocorticoid Receptor in Human Glioblastoma

The majority of glioblastoma (GBM) patients require the administration of dexamethasone (DEXA) to reduce brain inflammation. DEXA activates the glucocorticoid receptor (GR), which can consequently crosstalk with the mineralocorticoid receptor (MR). However, while GR signaling is well studied in GBM,...

Descripción completa

Detalles Bibliográficos
Autores principales: Aldaz, Paula, Fernández-Celis, Amaya, López-Andrés, Natalia, Arozarena, Imanol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584062/
https://www.ncbi.nlm.nih.gov/pubmed/34769089
http://dx.doi.org/10.3390/ijms222111656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584062/
https://www.ncbi.nlm.nih.gov/pubmed/34769089
http://dx.doi.org/10.3390/ijms222111656

Ejemplares similares